OBJECTIVES In recent years, the therapeutic implications of dyslipidemias have been clarified in large-scale epidemiologic surveys, and the validity of pharmacotherapy has been established. We investigated the practical realities of pharmacotherapy for dyslipidemias at a community hospital in Japan. METHODS Medical chart surveys were performed retrospectively on 451 dyslipidemic outpatients w...

OBJECTIVE To determine the prevalence of single and mixed dyslipidemias among patients treated with statins in clinical practice in France. METHODS This is a prospective, observational, cross-sectional, pharmacoepidemiologic study with a total of 2544 consecutive patients treated with a statin for at least 6 months. MAIN OUTCOME MEASURES Prevalence of isolated and mixed dyslipidemias of low...

background : various studies have indicated that dyslipidemia starts in childhood. there is a relationship between the concentration of blood lipids and atherosclerosis. in this study, we assessed the prevalence of dyslipidemia in elementary school children. methods: this cross-sectional study was performed on 1,626 (882 girls and 744 boys) elementary school children aged between 6 and 11 years...

background: the aim of this cross-sectional study was to investigate the relationship between body mass index (bmi), waist-to-hip ratio, and lipid parameters and serum thyroid-stimulating hormone (tsh) levels in healthy euthyroid individuals. methods: this cross-sectional study was conducted between june 1st and july 20th, 2013, at bushehr university of medical sciences. one hundred forty euthy...

Plasma levels of proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprotein C-III (apoC3) and small dense low density lipoprotein cholesterol (sdLDL-C), have been recently recognized as circulating atherosclerosis-related lipid measurements. We aimed to elucidate their associations with current dyslipidemias, and identify their levels at increased risk to dyslipidemia. A total of 1,6...

This article summarizes the principal publications and those evidence-based clinical trials on dyslipidemias, including their main findings and recommendations for practicing cardiologists and clinicians. Emphasis is given to the confirmed data regarding the pathophysiology as well as the diagnoses of dyslipidemias, and the established therapeutic approaches validated in multiple well supervise...

OBJECTIVE To determine the frequency of dyslipidemias in various autoimmune rheumatic diseases and the difference in lipid profile according to the activity of these diseases. STUDY DESIGN Cross-sectional study. PLACE AND DURATION OF STUDY The Rheumatology Department of Pakistan Institute of Medical Sciences (PIMS), Islamabad, from May 2010 to April 2011. METHODOLOGY All patients who pres...